Revvity (RVTY) Other Accumulated Expenses (2014 - 2016)

Revvity (RVTY) reported Other Accumulated Expenses of $126.1 million for Q1 2016, up 2.59% on a YoY basis from $123.0 million in Q1 2015, and up 2.59% quarter-over-quarter from $123.0 million in Q4 2014.

Revvity (RVTY) Other Accumulated Expenses (2014 - 2016) Analysis & Trends

Revvity has reported Other Accumulated Expenses for 2 years, with the latest figure at $126.1 million in Q1 2016.

  • For the quarter ending Q1 2016, Other Accumulated Expenses rose 2.59% year-over-year to $126.1 million; the trailing twelve-month figure through Jan 2016 stood at $126.1 million (up 2.59% YoY), and the FY2016 full-year result was $126.1 million, up 2.59% from the prior year.
  • Other Accumulated Expenses for Q1 2016 stood at $126.1 million, up from $123.0 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $126.1 million in Q1 2016, with the low at $123.0 million in Q4 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 30,010.71 Bn 30,010.25 Bn 1.11 Bn
2 Thermo Fisher Scientific 179.46 Bn 176.21 Bn 7.74 Bn
3 Danaher 130.33 Bn 124.64 Bn 3.59 Bn
4 Idexx Laboratories 44.44 Bn 44.24 Bn 722.74 Mn
5 Agilent Technologies 37.27 Bn 35.46 Bn 990.00 Mn
6 Iqvia Holdings 30.70 Bn 28.73 Bn 1.36 Bn
7 Natera 30.59 Bn 29.49 Bn 696.04 Mn
8 Illumina 24.86 Bn 23.71 Bn 721.00 Mn
9 Mettler Toledo International 23.06 Bn 23.00 Bn 555.82 Mn
10 Revvity 11.34 Bn 10.48 Bn 387.66 Mn

Historic Data

Download Data
DateValue
Jan 3, 2016 126.14 Mn
Dec 28, 2014 122.96 Mn